Research
Print page Print page
Switch language
The Capital Region of Denmark - a part of Copenhagen University Hospital
Published

Duration of hyperthyroidism and lack of sufficient treatment are associated with increased cardiovascular risk

Research output: Contribution to journalJournal articleResearchpeer-review

DOI

  1. Thyroid Peroxidase Antibodies and Prospective Live Birth Rate: A Cohort Study of Women with Recurrent Pregnancy Loss

    Research output: Contribution to journalJournal articleResearchpeer-review

  2. Incidence and Survival of Thyroid Cancer in Children, Adolescents, and Young Adults in Denmark: A Nationwide Study from 1980 to 2014

    Research output: Contribution to journalJournal articleResearchpeer-review

  3. Over- and Under-Treatment of Hypothyroidism Is Associated with Excess Mortality: A Register-Based Cohort Study

    Research output: Contribution to journalJournal articleResearchpeer-review

  4. How should thyroid-related quality of life be assessed? Recalled patient-reported outcomes compared with here-and-now measures

    Research output: Contribution to journalJournal articleResearchpeer-review

  1. Change in HbA1c concentration as decision parameter for frequency of HbA1c measurement

    Research output: Contribution to journalJournal articleResearchpeer-review

  2. Centenarian hip fracture patients: a nationwide population-based cohort study of 507 patients

    Research output: Contribution to journalJournal articleResearchpeer-review

  3. Vitamin D levels and Cancer Incidence in 217.244 individuals from Primary Health Care in Denmark

    Research output: Contribution to journalJournal articleResearchpeer-review

  4. Maternal short-term complications after planned cesarean delivery without medical indication: A registry-based study

    Research output: Contribution to journalJournal articleResearchpeer-review

View graph of relations

IMPORTANCE: Cardiovascular disease remains the most prevalent cause of death in hyperthyroidism. However, the impact on cardiovascular events of varying thyroid status and that of treatment remain unclarified.

OBJECTIVE: To investigate the association between hyperthyroidism and cardiovascular events in treated and untreated hyperthyroid individuals, as well as exploring the impact of cumulative periods of hyperthyroidism, as a proxy for undertreatment, on cardiovascular events.

DESIGN: A case-control study nested within a population-based cohort of individuals attending health services in Funen County, Denmark, in the period from 1995 to 2011. Data on comorbidities and mortality were collected from The Danish National Patient Register and The Danish Register of Causes of Death.

SETTING: Population-based.

PARTICIPANTS: 217 167 individuals with at least one serum-TSH measurement in the study period of 1995-2011. Hyperthyroidism was defined as at least two measurements of decreased serum TSH within 6 months, separated by at least 14 days. Main outcomes and measures: Incident cases of cardiovascular disease (myocardial infarction, atrial fibrillation, heart failure, stroke, and cardiovascular death) were matched with controls. Conditional logistic regression analyses were performed to calculate odds ratios (OR) for exposure to hyperthyroidism, adjusting for preexisting comorbidities.

RESULTS: 20 651 individuals experienced a cardiovascular event [9.5% incidence rate 13.2/1000 person years, 95% confidence interval (CI) 13.0 to 13.4]. Conditional logistic regression showed increased cardiovascular risk in untreated hyperthyroid patients compared to euthyroid individuals (OR 1.25, 95% CI, 1.06 to 1.48; p=.007), but not in the treated hyperthyroid patients [OR 1.04 (95% CI, 0.90 to 1.22; p=.57)]. OR for cardiovascular events per 6 months of decreased TSH was 1.09 (95% CI, 1.05 to 1.14; p<.001) in treated hyperthyroid individuals, and 1.10 (95% CI, 1.05 to 1.15; p<.001) in untreated hyperthyroid individuals.

CONCLUSION: Risk of cardiovascular disease was found increased in untreated hyperthyroid patients, and duration of decreased TSH associated with increasing risk of cardiovascular outcomes in both treated and untreated hyperthyroid individuals. This suggests that increased cardiovascular risk is not only driven by lack of treatment but also by insufficient therapy. Our results support timely treatment and careful monitoring of hyperthyroid patients in order to reduce cardiovascular risk.

Original languageEnglish
JournalThyroid : official journal of the American Thyroid Association
ISSN1050-7256
DOIs
Publication statusPublished - 13 Mar 2019

ID: 56289560